Gang Yin

18PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 14, 2026
Ubiquitination of MEIS1 by MDM2 serves as a switch for p53 stabilization and DNA damage response activation.

Jiaxin Liu, Yanxia Duan, Qing Xiao

|Dec 08, 2025
Overall survival according to time-of-day of immunochemotherapy for extensive-stage small cell lung cancer.

Zhe Huang, Zhaohui Ruan, Shidong Xu

|Nov 27, 2025
Over-Expression of TNFRSF12A Promotes Immune Suppression and Facilitates Angiogenesis in Triple-Negative Breast Cancer.

Can Jiang, Zhengwei Zhou, Guang Shu

|Mar 06, 2025
Metabolic reprogramming in cancer and senescence.

Yuzhu Zhang, Jiaxi Tang, Can Jiang

|Nov 27, 2024
The Role of the CPT Family in Cancer: Searching for New Therapeutic Strategies.

Yanxia Duan, Jiaxin Liu, Ailin Li

|Jun 03, 2024
Tweety homolog 3 promotes colorectal cancer progression through mutual regulation of histone deacetylase 7.

Pengyan Lu, Shumin Deng, Jiaxin Liu

Pageof 3

Frequent Collaborators

2 joint publications

Qing Xiao

2 joint publications

Jiaxin Liu

2 joint publications

Guang Shu

1 joint publications

Jiaqi Liu